2019-nCoV Dhexdhexaadinta Qalabka Tijaabada Kahortagga Jirka (qaabka dahabka colloidal)
Hordhac
Barootiinka sare waxaa loo aqoonsaday inuu yahay bartilmaameed antigenic ee horumarinta tallaalka ka dhanka ah 2019-nCoV, iyo RBD ee borotiinka S waa xudunta ugu weyn.
In ka badan 180 musharax oo tallaal, oo ku saleysan dhowr goobood oo kala duwan ayaa hadda ku jira horumar ka dhan ah 2019-nCoV.
borotiinka S waa bartilmaameedka ugu weyn ee ka hortagga unugyada difaaca;
Qaar badan oo ka mid ah unugyada difaaca jirka waxay beegsadaan RBD ee borotiinka S.
Sida loo qiimeeyo waxtarka tallaalka 2019-nCoV? --- Dhexdhexaadinta Kahortagga Jirka
Faa'iidooyinka
Baaritaanka tallaalka ka hor
Kahor tallaalka, musharrixiinta waxay ogaan karaan antibody-ka-hortagga RBD si loo go'aamiyo haddii tallaalku lagama maarmaan yahay;
Inta badan tallaalada waa la daboolay
Waxay ogaan kartaa ka-hortagga difaaca jirka ee ay soo saaraan inta badan tallaalada suuqa;
Degdeg ah oo ku habboon
Qalliinku waa sahlan yahay, qalab lagu ogaanayo looma baahna, natiijooyinka waxaa lagu heli karaa 15 daqiiqo gudahood.
Shaqada aqoonsiga
Waxay kala saari kartaa kahortaga difaaca jirka ee 2019-nCoV ee uu soo saaray tallaalka 2019-nCoV ama ka-hortagga uu soo saaray caabuqa 2019-nCoV ee nooc ka mid ah tallaallada, sida tallaalka Viral vector (aan-ku-dabayn), tallaalka saldhigga RNA iyo tallaalka borotiinka hoosaadka. ;
Baaritaanka dhiigga oo dhan
Tijaabada dhiigga oo dhan ayaa ka dhigaysa qalliinka mid ku habboon.
Qaybaha
| Qaybaha | Waxyaabaha ugu muhiimsan | Tirada soo darida (Tirada) | |
| 1 T/Kit | 5 T/Qalabka | ||
| Kaarka tijaabada | Xariijimo tijaabo ah oo ka kooban dahab kolloidal ah oo lagu sumadeeyay anti-bini'aadamka IgG antibody, dahab kolloidle ah oo ku suntan anti-digaag IgY antibody, 2019-nCoV S-RBD borotiinka recombinant, 2019-nCoV recombinant N borotiin, Chicken IgY antibody | 1 pc | 5 pcs |
| Tusaalaha lagu qasi karo | 0.01M Fosfate xalinta, 0.5% Tween-20 | 0.5ml | 2.5ml |
Waxqabadka
| Hecin reagent | Baaritaanka dhexdhexaadinta fayraska serum ee bukaan-socodka | Wadarta | |
| Wanagsan | xun | ||
| Wanagsan | 84 | 17 | 101 |
| xun | 8 | 190 | 198 |
| Wadarta | 92 | 207 | 299 |
| Dareenka bukaan socodka | 84/92 91.30% (95% CI: 83.58%～96.17%) | ||
| Gaar ahaan bukaan-socodka | 190/207 91.79% (95% CI: 87.18%～95.14%) | ||
| Saxnaanta | 274/299 91.64% (95% CI: 87.90%～94.52%) | ||
Waxqabadka Hecin reagent ee lidka ku ah Habka Isbarbardhigga ee shaybaarrada serum/plasma.
| Hecin reagent | Baaritaanka dhexdhexaadinta fayraska serum ee bukaan-socodka | Wadarta | |
| Wanagsan | xun | ||
| Wanagsan | 84 | 16 | 100 |
| xun | 8 | 191 | 199 |
| Wadarta | 92 | 207 | 299 |
| Dareenka bukaan socodka | 84/92 91.30% (95% CI: 83.58%～96.17%) | ||
| Gaar ahaan bukaan-socodka | 191/207 92.27% (95% CI: 87.75%～95.52%) | ||
| Saxnaanta | 275/299 91.97% (95% CI: 88.29%～94.79%) | ||
Waxqabadka Hecin reagent ka dhanka ah Habka Isbarbardhigga ee shaybaarada dhiigga oo dhan.
Baaxadda codsiga
Tallaalka ka hor
Go'aanso haddii ay qaadeen cudurka 'coronavirus' cusub iyo inay weli u baahan yihiin in la tallaalo;
Muddada tallaalka
Go'aanso in antibody-ka-hortagga cusub la soo saaray iyo in kale;
Marxaladda dambe ee tallaalka
Marka loo eego aagga cudurka faafa ee 2019-nCoV, waxaa la soo jeediyay in la ogaado jiritaanka 2019-nCoV ka-hortagga kahortagga si joogto ah saddexdii biloodba mar.
Is barbar dhig 2019-nCoV S-RBD Dhexdhexaadinta Qalabka Tijaabada Kahortagga Jirka (Qaabka Dahabka Kolloital)
Hel natiijooyinka baaritaanka S-RBD IgG, N borotiinka IgG isku mar, falanqaynta natiijada imtixaanka.
*Waxay u baahan tahay baaritaan dheeri ah: Waxaa lagu talinayaa in lagu tijaabiyo ama lagu tijaabiyo agabka kale ee habka cufnaanta saxda ah.
Habka Imtixaanka
Shahaadada Diiwaangelinta
Tilmaamaha alaabta
Hecin JT09-Sawirka Alaabta
Hecin JT09-50PCS Sawirka Alaabta
JT09-50T
